Interpace Diagnostics Announces CIGNA’s Expansion of Coverage to Now Include ThyraMIR®
July 26, 2018 08:37 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides...
Interpace Diagnostics Expands Application of Pancreatic Cancer Test
July 19, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., July 19, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company” or “Interpace Diagnostics”), a fully integrated commercial and bioinformatics...
Interpace Diagnostics Announces Coverage of Thyroid Testing by Blue Cross Blue Shield of Florida
June 11, 2018 08:00 ET
|
Interpace Diagnostics Group, Inc.
Florida’s Largest Health Plan Adds Coverage for ThyGenX® and ThyraMIR® PARSIPPANY, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the...
Interpace Diagnostics to Attend and Present at the 8th Annual LD Micro Invitational Conference
June 04, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics Presents New Data on PancraGEN® at Digestive Disease Week
June 01, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
WASHINGTON, June 01, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company” or “Interpace”), a fully integrated commercial and bioinformatics company that provides...
Interpace Diagnostics Enters into Agreement with Nationally Renowned Institution
May 30, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides...
Interpace Diagnostics Group Reports First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments
May 15, 2018 08:00 ET
|
Interpace Diagnostics Group, Inc.
Revenue Grew 39% Over the Prior Year’s Quarter and 10% Over the Prior Period Record Quarterly Revenue of $4.8 Million and Record Quarterly Cash Receipts of $4.4 Million Cash & Cash Equivalents...
Interpace Diagnostics Announces Launch of New Thyroid Test
May 14, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
BOSTON, May 14, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides...
Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments on Tuesday, May 15, 2018
May 11, 2018 09:10 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., May 11, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
May 10, 2018 09:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...